Crixus Bh3 Acquisition Stock Current Valuation
BHACUDelisted Stock | USD 10.63 0.00 0.00% |
Valuation analysis of Crixus Bh3 Acquisition helps investors to measure Crixus Bh3's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Crixus Bh3's price fluctuation is very steady at this time. Calculation of the real value of Crixus Bh3 Acquisition is based on 3 months time horizon. Increasing Crixus Bh3's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Crixus Bh3's intrinsic value may or may not be the same as its current market price of 10.63, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 10.63 | Real 9.47 | Hype 10.63 | Naive 10.94 |
The intrinsic value of Crixus Bh3's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Crixus Bh3's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Crixus Bh3 Acquisition helps investors to forecast how Crixus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Crixus Bh3 more accurately as focusing exclusively on Crixus Bh3's fundamentals will not take into account other important factors: Crixus Bh3 Acquisition Company Current Valuation Analysis
Crixus Bh3's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Crixus Bh3 Current Valuation | 75.01 M |
Most of Crixus Bh3's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Crixus Bh3 Acquisition is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Crixus Bh3 Acquisition has a Current Valuation of 75.01 M. This is 99.77% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The current valuation for all United States stocks is 99.55% higher than that of the company.
Crixus Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Crixus Bh3's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Crixus Bh3 could also be used in its relative valuation, which is a method of valuing Crixus Bh3 by comparing valuation metrics of similar companies.Crixus Bh3 is currently under evaluation in current valuation category among its peers.
Crixus Fundamentals
Return On Asset | -0.0818 | ||||
Current Valuation | 75.01 M | ||||
Shares Owned By Institutions | 0.01 % | ||||
Price To Earning | 12.60 X | ||||
EBITDA | (1.69 M) | ||||
Net Income | 7.88 M | ||||
Cash And Equivalents | 618.98 K | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 346.35 K | ||||
Debt To Equity | 24.20 % | ||||
Current Ratio | 0.27 X | ||||
Book Value Per Share | (0.72) X | ||||
Cash Flow From Operations | (1.94 M) | ||||
Short Ratio | 10.99 X | ||||
Earnings Per Share | 0.80 X | ||||
Market Capitalization | 22.48 M | ||||
Total Asset | 25.34 M | ||||
Retained Earnings | (1.55 M) | ||||
Working Capital | (2.1 M) | ||||
Current Asset | 629 K | ||||
Current Liabilities | 8 K | ||||
Net Asset | 25.34 M |
About Crixus Bh3 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Crixus Bh3 Acquisition's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Crixus Bh3 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Crixus Bh3 Acquisition based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Crixus Stock
If you are still planning to invest in Crixus Bh3 Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Crixus Bh3's history and understand the potential risks before investing.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |